Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 13 February 2009, doi:10.1136/bmj.b553
Cite this as: BMJ 2009;338:b553
Geoff Watts, freelance journalist
1 London
geoff@scileg.freeserve.co.uk
Details of how the new research excellence framework will assess UK research are expected later this year. Geoff Watts looks at the possibilities for fairer evaluation of applied medical research
| The first 150 words of the full text of this article appear below. |
The RAE is dead; long live the REF.1 Were talking research quality: whats good and whats not; whats worth doing and what isnt. But how is good quality to be defined? And to what extent should that judgment take account not only of the intellectual excellence of a research programme but also, in the case of medicine, its value to clinical practice? The question is a live one, and set to become livelier. One answer may lie in a still embryonic form of appraisal: the "social impact" of research.
For the benefit of readers who dont follow the vicissitudes of the research community, the more familiar of these three letter abbreviations, RAE, stands for research assessment exercise: the process by which, until last year, the Higher Education Funding Council of England surveyed the quality of research carried out in British universities. The REF, the research excellence framework,2 is its replacement.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?